Maria Camelia Stancioaica
11:00 am
-
11:15 am
Exhibition Hall
Focusing on FLT3 inhibitors in acute myeloid leukemia
FLT3 inhibitors are a class of targeted therapies used in the treatment of acute myeloid leukemia (AML) patients who have FLT3 gene mutations. The FLT3 gene mutations, particularly FLT3-ITD (internal tandem duplication) and FLT3-TKD (tyrosine kinase domain) mutations, are associated with aggressive disease and poorer outcomes. FLT3 inhibitors specifically target the abnormal FLT3 receptor on leukemia cells, aiming to inhibit its activity and slow down the growth of leukemia cells..
12:00 pm
-
12:15 pm
Exhibition Hall
Panel discussion /All speakers
Panel discussion /All speakers for EET Session 2: Acute myeloid leukemia - Therapies